A Decade of Reinforcing Business Integrity Making Asia-Pacific better prepared for COVID-19

Published on: 07 September 2020

Over the last decade the Asia-Pacific has seen an unprecedented shift in the adoption and implementation of high-standard ethical business conduct across its healthcare enterprises, including in the biopharmaceutical sector. This positive uptake of integrity had positioned the region to better prepare for, and now to hope to recover from, the current pandemic.